For many years, platinum-based chemotherapy has been one of the mainstays for advanced testicular cancer. Painful peripheral ...

The Phase Ia trial is designed to assess the company’s drug designed to target chemicals thought to be a cause of Alzheimer’s disease.

Cognitive problems like more diminished attention, but better immediate recall and memory may help predict Lewy body dementia ...

Am I a doomed man? When I was 25, I survived a battle with testicular cancer. The good news is that 45 years later, after two kids and ...

Researchers uncovered new findings about involuntary muscle movements that come with long-term administration of Parkinson's ...

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

A new blood test may be key to uncovering new Alzheimer's disease therapies, allowing patients to be treated before the condition becomes severe.

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

"Getting addiction off the streets and alleyways – and one step closer to treatment – is a win for all of society." ...

Several recent studies have suggested HRT is a risk factor in various conditions, notably Alzheimer's - now UK boffins have ...

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, fibrosis, stroke, dementia, and Alzheimer's disease, announced its ...